The Leukemia & Lymphoma Society Applauds New Missouri Law that Limits Costs for Cancer Patients on Oral Forms of Treatment
(March 19, 2014) ? Today Missouri Gov. Jay Nixon signed into a law a bill that prohibits insurance companies from imposing significantly higher cost-sharing for cancer patients who take their anticancer medications orally as compared to those patients who receive their treatments intravenously in a clinical setting.
Both the Gateway and MidAmerica Chapters of The Leukemia & Lymphoma Society (LLS) and their volunteers were active in urging passage of the bill.
As The Leukemia & Lymphoma Society and our partners in the community invest in research for cures, we want to ensure access to the best cancer treatments for every Missourian,? said Debbie Kersting, Executive Director of the Leukemia & Lymphoma Society ? Gateway Chapter. ?We applaud Governor Nixon and members of the General Assembly for their strong support of this bill, which will put affordable, effective cancer treatment within reach for Missourians across the state.?
The new law, which will be effective January 2015, will limit out of pocket costs to $75 for a thirty day supply of anti-cancer pills. The $75 cap could increase annually, but wouldn't be able to rise above the consumer price index in a given year.
The state Senate unanimously passed the bill on Feb. 20, and the House passed the bill on March 5, sending it to the Governor?s desk for his signature.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.